Primary and secondary prevention of ischemic heart disease in women

Area of Science:

• Cardiology
• Women's Health
• Preventive Medicine

Background:

• Cardiovascular disease (CVD) is the leading cause of death for women globally.
• While awareness and trial inclusion for women have improved, leading to reduced CVD mortality, women still experience higher mortality rates than men.
• There is a concerning rise in CVD among younger women, highlighting an unmet need for effective prevention strategies.

Purpose of the Study:

• To review current data on primary and secondary prevention therapies for ischemic heart disease (IHD) specifically in women.
• To identify gaps and opportunities in the prevention of IHD in the female population.
• To inform clinical practice and future research directions for women's cardiovascular health.

Main Methods:

• Comprehensive literature search of clinical trials and observational studies.
• Analysis of data focusing on the efficacy and safety of preventive therapies in women.
• Synthesis of evidence regarding primary and secondary prevention strategies for ischemic heart disease.

Main Results:

• Data indicates a decline in cardiovascular disease mortality among women due to increased awareness and trial participation.
• Despite progress, women continue to have higher mortality rates from cardiovascular disease compared to men.
• An increasing incidence of cardiovascular disease is observed in younger women, underscoring the need for targeted preventive measures.

Conclusions:

• Preventive therapies are crucial for addressing the persistent gap in cardiovascular disease outcomes between men and women.
• Continued research and guideline development focusing on women are essential for reducing the burden of ischemic heart disease.
• Implementing evidence-based preventive strategies is key to improving cardiovascular health and reducing mortality in women across all age groups.